51±¾É«

ITP and the Center of QuantumBioSciences is part of newly approved Collaborative Research Center 1279

ITP and the Center of QuantumBioSciences is part of newly approved Collaborative Research Center 1279 on “Exploiting the Human Peptidome for Novel Antimicrobial and Anticancer Agentsâ€�. Our team contributes to the CRC with a project on hyperpolarized nanodiamond as contrast agents for cancer research. Funded initially for a period of 4 years the CRC may be extended for a duration of up to 12 years.

<link med fakultaet med-detailseiten news-detail article rund-121-millionen-neuer-peptid-sonderforschungsbereich-koerpereigene-wirkstoffe-gegen-hiv>www.uni-ulm.de/med/fakultaet/med-detailseiten/news-detail/article/rund-121-millionen-neuer-peptid-sonderforschungsbereich-koerpereigene-wirkstoffe-gegen-hiv/

Contact

Ulm University
Institute of Theoretical Physics
Albert-Einstein-Allee 11
D - 89081 Ulm
Germany

Tel: +49 731 50 22911
Fax: +49 731 50 22924

Office: Building M26, room 4117

Click if you are interested in joining the group.

Most Recent Papers

A single-molecule spin–photon interface, ,

Gaussian Time-Translation Covariant Operations: Structure, Implementation, and Thermodynamics, ,

PHIP sequences and dipolar fields II - dual-channel control, ,

PHIP sequences and dipolar fields I - single spin control, ,

Chirality-Induced Orbital Selectivity through Linear-Orbital Coupling, ,